Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_assertion description "[In vitro, Zyflamend inhibited the proliferation of pancreatic cancer cell lines regardless of p53 status and also enhanced gemcitabine-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_assertion evidence source_evidence_literature NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_assertion SIO_000772 21935918 NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_assertion wasDerivedFrom befree-20150227 NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_assertion wasGeneratedBy ECO_0000203 NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP753058.RAPeO4UF4MHDiO8-tcp-FNguMftASRFizlJGiNV4tQ1gI130_provenance.